Announcements Trials
Browse Landscape

Phase

Phase 1/2 1

Status

Completed 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Head & Neck 1

Conditions

Head and Neck Neoplasms 8Squamous Cell Carcinoma of Head and Neck 6Nasopharyngeal Carcinoma 4Ovarian Neoplasms 3Oropharyngeal Neoplasms 3Neoplasm Metastasis 3Melanoma 3Esophageal Neoplasms 3Vaginal Neoplasms 2Uterine Cervical Neoplasms 2Stomach Neoplasms 2Recurrence 2Penile Neoplasms 2Neoplasms 2Hodgkin Disease 2Carcinoma, Squamous Cell 2Anus Neoplasms 2Uveal Melanoma 1Thyroid Neoplasms 1Smooth Muscle Tumor 1Sarcoma, Synovial 1Pheochromocytoma 1Paraganglioma 1Papillomavirus Infections 1Neuroendocrine Tumors 1Lymphoma, T-Cell 1Lymphoma, Non-Hodgkin 1Lymphoma, Large B-Cell, Diffuse 1Carcinoma, Non-Small-Cell Lung 1Breast Neoplasms 1

Interventions

fludarabine phosphate 1Genetic Engineering 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Adenoviridae Infections × fludarabine phosphate × Head & Neck × Clear all
NCT03754933 2025-03-27

Safety and Efficacy of Repeat Administration of Ad/PNP and Fludarabine Phosphate in Patients With Local Head/Neck Cancer

GeoVax, Inc.

Phase 1/2 Completed
10 enrolled 22 charts
Head & Neck

Squamous Cell Carcinoma of Head and Neck, Adenoviridae Infections, Head and Neck Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡